$3.59 Billion is the total value of HHLR ADVISORS, LTD.'s 30 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 55.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TAL | Buy | TAL EDUCATION GROUPsponsored ads | $411,689,000 | +106.4% | 11,410,453 | +52.6% | 11.47% | +38.6% |
| IQ | Buy | IQIYI INCsponsored ads | $300,375,000 | +1683.2% | 12,557,488 | +1008.5% | 8.37% | +1097.0% |
| FB | New | FACEBOOK INCcl a | $196,628,000 | – | 1,179,600 | +100.0% | 5.48% | – |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $119,956,000 | +55.5% | 1,498,516 | +4.7% | 3.34% | +4.4% |
| SE | New | SEA LTDsponsored ads | $101,136,000 | – | 4,300,000 | +100.0% | 2.82% | – |
| MLCO | Buy | MELCO RESORTS AND ENTMT LTDadr | $99,299,000 | +21724.0% | 4,395,700 | +16928.4% | 2.77% | +14457.9% |
| ESGR | New | ENSTAR GROUP LIMITED | $94,567,000 | – | 543,487 | +100.0% | 2.63% | – |
| PDD | Buy | PINDUODUO INCsponsored ads | $77,676,000 | +100.1% | 3,132,096 | +81.0% | 2.16% | +34.4% |
| BILI | Buy | BILIBILI INCspons ads rep z | $65,420,000 | +105.9% | 3,452,231 | +58.5% | 1.82% | +38.2% |
| MYOK | Buy | MYOKARDIA INC | $50,742,000 | +21.0% | 975,987 | +13.7% | 1.41% | -18.8% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $50,304,000 | +71.0% | 2,579,708 | +15.7% | 1.40% | +14.8% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $33,156,000 | -15.0% | 1,835,888 | +32.2% | 0.92% | -42.9% |
| GOSS | New | GOSSAMER BIO INC | $20,316,000 | – | 937,500 | +100.0% | 0.57% | – |
| EDU | New | NEW ORIENTAL ED & TECH GRP Ispon adr | $252,000 | – | 2,800 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.